KAYA, M. Et Al. 2021. Intravitreal ranibizumab and dexamethasone implant injections as primary treatment of diabetic macular edema: simultaneously double protocol. EYE , vol.35, no.3 , 777-785.

KAYA, M., KOÇAK, N., ÖZTÜRK, A. T., Bolluk, V., AYHAN, Z., & Kaynak, S., (2021). Intravitreal ranibizumab and dexamethasone implant injections as primary treatment of diabetic macular edema: simultaneously double protocol. EYE , vol.35, no.3, 777-785.

KAYA, MAHMUT Et Al. "Intravitreal ranibizumab and dexamethasone implant injections as primary treatment of diabetic macular edema: simultaneously double protocol," EYE , vol.35, no.3, 777-785, 2021

KAYA, MAHMUT Et Al. "Intravitreal ranibizumab and dexamethasone implant injections as primary treatment of diabetic macular edema: simultaneously double protocol." EYE , vol.35, no.3, pp.777-785, 2021

KAYA, M. Et Al. (2021) . "Intravitreal ranibizumab and dexamethasone implant injections as primary treatment of diabetic macular edema: simultaneously double protocol." EYE , vol.35, no.3, pp.777-785.

@article{article, author={MAHMUT KAYA Et Al. }, title={Intravitreal ranibizumab and dexamethasone implant injections as primary treatment of diabetic macular edema: simultaneously double protocol}, journal={EYE}, year=2021, pages={777-785} }